10.1007/s00424-013-1347-4Pflugers Archiv European Journal of Physiology4663563-576PFLA
Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is a mainstay of acute ischemic s...
Abstract In acute ischemic stroke, the only FDA-approved drug; recombinant tissue plasminogen activa...
Transient receptor potential melastatin 4 (TRPM4) is a unique member of the TRPM protein family and,...
The transient receptor potential melastatin 4 (TRPM4) channel has been suggested to play a key role ...
The transient receptor potential melastatin 4 (TRPM4) channel has been suggested to play a key role ...
Reperfusion therapy is currently the gold standard treatment for acute ischemic stroke. However, rep...
In stroke and other neurological diseases, Transient Receptor Potential Melastatin 4 (TRPM4) has bee...
Abstract Introduction TRPM2 channels have been suggested to play a role in ischemic neuronal injur...
Ischemic stroke causes a heavy health burden worldwide, with over 10 million new cases every year. D...
Transient receptor potential melastatin-4 (TRPM4) is activated by an increase in intracellular Ca2+ ...
Background and Purpose: Smooth muscle transient receptor potential melastatin 4 (TRPM4) channels pla...
International audienceRecombinant tissue plasminogen activator (rt-PA) is the only pharmacological t...
The nonselective monovalent cation channel transient receptor potential melastatin 4 (Trpm4) is tran...
Original article can be found at: http://www.informaworld.com/smpp/title~content=t713597278 Copyrigh...
<div><p>Background</p><p>Hemorrhagic transformation is a major complication of ischemic stroke, is l...
Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is a mainstay of acute ischemic s...
Abstract In acute ischemic stroke, the only FDA-approved drug; recombinant tissue plasminogen activa...
Transient receptor potential melastatin 4 (TRPM4) is a unique member of the TRPM protein family and,...
The transient receptor potential melastatin 4 (TRPM4) channel has been suggested to play a key role ...
The transient receptor potential melastatin 4 (TRPM4) channel has been suggested to play a key role ...
Reperfusion therapy is currently the gold standard treatment for acute ischemic stroke. However, rep...
In stroke and other neurological diseases, Transient Receptor Potential Melastatin 4 (TRPM4) has bee...
Abstract Introduction TRPM2 channels have been suggested to play a role in ischemic neuronal injur...
Ischemic stroke causes a heavy health burden worldwide, with over 10 million new cases every year. D...
Transient receptor potential melastatin-4 (TRPM4) is activated by an increase in intracellular Ca2+ ...
Background and Purpose: Smooth muscle transient receptor potential melastatin 4 (TRPM4) channels pla...
International audienceRecombinant tissue plasminogen activator (rt-PA) is the only pharmacological t...
The nonselective monovalent cation channel transient receptor potential melastatin 4 (Trpm4) is tran...
Original article can be found at: http://www.informaworld.com/smpp/title~content=t713597278 Copyrigh...
<div><p>Background</p><p>Hemorrhagic transformation is a major complication of ischemic stroke, is l...
Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is a mainstay of acute ischemic s...
Abstract In acute ischemic stroke, the only FDA-approved drug; recombinant tissue plasminogen activa...
Transient receptor potential melastatin 4 (TRPM4) is a unique member of the TRPM protein family and,...
DOI
Add to ORKG